Biotechnology News

Oslo (Norway), 21 October 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today informed that AstraZeneca has elected not to enter into a definitive agreement for the...

Please read the full announcement in PDF Attachment 2020_58_Q32020_CompanyAnnouncement ...

SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer       ·New investors include 4BIO Capital, UPMC Enterprises, Jeito Capital and Ysios...

COMMUNIQUÉ DE PRESSE — INFORMATIONS RÉGLEMENTÉES 21 OCTOBRE 2020, 07h00 CEST IRVINE, CA, et HERSTAL, BELGIQUE – 21 octobre 2020 – MDxHealth SA (Euronext : MDXH.BR), une société spécialisée dans le...

NEWS RELEASE - REGULATED INFORMATION 21 OCTOBER 2020, 07:00 A.M. CEST IRVINE, CA, and HERSTAL, BELGIUM – October 21, 2020 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular...

GUANGZHOU, China, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that new data for its early detection ELSA-seq test...

GUANGZHOU, China, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...

Testing volume for DetermaRx more than doubled in Q3 2020 Growing hospital and physician adoption at large community practices and National Comprehensive Cancer Network (NCCN) and NCI-designated...

HOLLISTON, MA., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2020 before the market opens on...

GUILFORD, Conn., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company...